ES2103904T3 - Compuestos derivados de las beta-carbolinas ligantes del receptor de las benzodiacepinas que tienen un efecto agonista inverso y antagonista con respecto a las benzodiacepinas y medicamentos que los contienen. - Google Patents

Compuestos derivados de las beta-carbolinas ligantes del receptor de las benzodiacepinas que tienen un efecto agonista inverso y antagonista con respecto a las benzodiacepinas y medicamentos que los contienen.

Info

Publication number
ES2103904T3
ES2103904T3 ES92400351T ES92400351T ES2103904T3 ES 2103904 T3 ES2103904 T3 ES 2103904T3 ES 92400351 T ES92400351 T ES 92400351T ES 92400351 T ES92400351 T ES 92400351T ES 2103904 T3 ES2103904 T3 ES 2103904T3
Authority
ES
Spain
Prior art keywords
benzodiacepines
sub
alcoxi
beta
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400351T
Other languages
English (en)
Inventor
Robert Dodd
Pierre Potier
Jean Rossier
Gilbert Dorey
Laurent Dubois
De Carvalho Lia Prado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2103904T3 publication Critical patent/ES2103904T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DERIVADOS DE LAS (BETA)-CARBOLINAS Y QUE SON LIGANDOS DEL RECEPTOR DE LAS BENZODIACEPINAS QUE TIENEN UN EFECTO AGONISTA INVERSO Y ANTAGONISTA RESPECTO DE LAS BENZODIACEPINAS. ESTOS COMPUESTOS RESPONDEN A LAS FORMULAS (I), (II): EN LAS QUE: X ES O, S, O REPRESENTA EL RADICAL -N(R SUB 6)-C(=O)-CH SUB 2-X, R SUB 1 ES UN RADICAL HIDROXI, ALCOXI, ALQUIL SUSTITUIDO POR UN RADICAL HIDROXI O ALCOXI, R SUB 2 ES UN ATOMO DE HIDROGENO O UN RADICAL ALQUIL, HIDROXI, ALCOXI, BENCILOXI, PUDIENDO DICHOS RADICALES ESTAR EVENTUALMENTE SUSTITUIDOS, R SUB 3, R SUB 4, R SUB 5 Y R SUB 6 SON ELEGIDOS ENTRE EL ATOMO DE HIDROGENO O UN RADICAL ALQUILO EVENTUALMENTE SUSTITUIDO POR UN RADICAL HIDROXI, ALCOXI, ALCOXI-CARBONILMETILO, ASI COMO A LOS DERIVADOS TETRAHIDRO DE (BETA)-CARBOLINA CORRESPONDIENTES Y A LAS SALES O DERIVADOS DE AMONIO CUATERNARIOS DE ESTOS COMPUESTOS FARMACEUTICAMENTE ACEPTABLES.
ES92400351T 1991-02-12 1992-02-11 Compuestos derivados de las beta-carbolinas ligantes del receptor de las benzodiacepinas que tienen un efecto agonista inverso y antagonista con respecto a las benzodiacepinas y medicamentos que los contienen. Expired - Lifetime ES2103904T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101595A FR2672602B1 (fr) 1991-02-12 1991-02-12 Composes derives des beta-carbolines ligands du recepteur des benzodiazepines ayant un effet agoniste inverse et antagoniste vis-a-vis des benzodiazepines et medicaments les contenant.

Publications (1)

Publication Number Publication Date
ES2103904T3 true ES2103904T3 (es) 1997-10-01

Family

ID=9409607

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400351T Expired - Lifetime ES2103904T3 (es) 1991-02-12 1992-02-11 Compuestos derivados de las beta-carbolinas ligantes del receptor de las benzodiacepinas que tienen un efecto agonista inverso y antagonista con respecto a las benzodiacepinas y medicamentos que los contienen.

Country Status (10)

Country Link
US (1) US5258385A (es)
EP (1) EP0499527B1 (es)
JP (1) JPH06211841A (es)
AT (1) ATE152452T1 (es)
CA (1) CA2061065A1 (es)
DE (1) DE69219379T2 (es)
DK (1) DK0499527T3 (es)
ES (1) ES2103904T3 (es)
FR (1) FR2672602B1 (es)
GR (1) GR3024291T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW251284B (es) * 1992-11-02 1995-07-11 Pfizer
GB9503601D0 (en) * 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
GR3024291T3 (en) 1997-10-31
EP0499527A1 (fr) 1992-08-19
EP0499527B1 (fr) 1997-05-02
JPH06211841A (ja) 1994-08-02
CA2061065A1 (fr) 1992-08-13
FR2672602B1 (fr) 1993-06-04
DE69219379T2 (de) 1997-12-11
DK0499527T3 (da) 1997-11-03
FR2672602A1 (fr) 1992-08-14
US5258385A (en) 1993-11-02
ATE152452T1 (de) 1997-05-15
DE69219379D1 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
ES2194937T3 (es) Compuestos ciclicos, su produccion y uso como antagonistas de los receptores de taquiquinina.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
ES2189330T3 (es) Derivados heterociclicos n6 de la adenosina sustituidos.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
DE69318854D1 (de) Spiroazacyclischderivate als substanz p antagonisten
NL300103I2 (nl) Toepassing van tetrahydrocarbazoolderivaten als 5HT1-receptoragonisten.
ES2072096T3 (es) 4-fenilpiperidinas n-sustituidas antagonistas de opioides.
ES2059335T3 (es) Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
ES2170211T3 (es) Compuestos azaheterociclicos que tienen actividad antagonista de los receptores de taquiquinina; nk1 y nk2.
UY24555A1 (es) Nuevos compuestos
ES2007318A4 (es) Compuestos de imidazol y composiciones biocidas que los comprenden.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
ECSP941156A (es) 3 bencilaminometil piperidinas substituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
TR199801211T2 (xx) Takikinin resept�r antagonistleri olarak 1-(1,2-�ift-ikameli piperidinil ) -4-ikameli piperidin t�revleri.
FI980341A0 (fi) 2-oksi-indolijohdannaisia
HK55797A (en) Fluoro substituted benzocycloheptapyridine compounds compositions and methods of use as antihistaminic compounds
DE69232883D1 (de) Substituierte heterocyklische derivate, verwendbar als plättchenaggregationshemmstoffe
ES2150039T3 (es) Benzonitrilos como 5-ht agonistas y antagonistas.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
GB8518658D0 (en) Medicaments
ES2160951T3 (es) Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499527

Country of ref document: ES